|
US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
|
JPS61176523A
(ja)
*
|
1985-01-30 |
1986-08-08 |
Teruhiko Beppu |
制癌剤
|
|
US5055608A
(en)
*
|
1988-11-14 |
1991-10-08 |
Sloan-Kettering Institute For Cancer Research |
Novel potent inducers of thermal differentiation and method of use thereof
|
|
US5608108A
(en)
*
|
1988-11-14 |
1997-03-04 |
Sloan-Kettering Institute For Cancer Research |
Potent inducers of terminal differentiation and method of use thereof
|
|
US5175191A
(en)
*
|
1988-11-14 |
1992-12-29 |
Sloan-Kettering Institute For Cancer Research |
Potent inducers of terminal differentiation and methods of use thereof
|
|
US5369108A
(en)
*
|
1991-10-04 |
1994-11-29 |
Sloan-Kettering Institute For Cancer Research |
Potent inducers of terminal differentiation and methods of use thereof
|
|
US5700811A
(en)
|
1991-10-04 |
1997-12-23 |
Sloan-Kettering Institute For Cancer Research |
Potent inducers of terminal differentiation and method of use thereof
|
|
USRE38506E1
(en)
*
|
1991-10-04 |
2004-04-20 |
Sloan-Kettering Institute For Cancer Research |
Potent inducers of terminal differentiation and methods of use thereof
|
|
US5635532A
(en)
*
|
1991-10-21 |
1997-06-03 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Compositions and methods for therapy and prevention of pathologies including cancer, AIDS and anemia
|
|
JP3170069B2
(ja)
*
|
1992-10-06 |
2001-05-28 |
日水製薬株式会社 |
徐放性顆粒剤
|
|
US6043389A
(en)
*
|
1997-03-11 |
2000-03-28 |
Mor Research Applications, Ltd. |
Hydroxy and ether-containing oxyalkylene esters and uses thereof
|
|
US6030961A
(en)
|
1997-03-11 |
2000-02-29 |
Bar-Ilan Research & Development Co., Ltd. |
Oxyalkylene phosphate compounds and uses thereof
|
|
US6124495A
(en)
|
1997-03-11 |
2000-09-26 |
Beacon Laboratories, Inc. |
Unsaturated oxyalkylene esters and uses thereof
|
|
US6231880B1
(en)
*
|
1997-05-30 |
2001-05-15 |
Susan P. Perrine |
Compositions and administration of compositions for the treatment of blood disorders
|
|
AUPO721997A0
(en)
|
1997-06-06 |
1997-07-03 |
Queensland Institute Of Medical Research, The |
Anticancer compounds
|
|
US6262116B1
(en)
*
|
1998-01-23 |
2001-07-17 |
Sloan-Kettering Institute For Cancer Research |
Transcription therapy for cancers
|
|
EP1123309A2
(en)
|
1998-10-13 |
2001-08-16 |
Fujisawa Pharmaceutical Co., Ltd. |
Cyclic tetrapeptides and their use as histone deacetylase inhibitor
|
|
JP2003500052A
(ja)
|
1999-05-03 |
2003-01-07 |
メチルジーン インコーポレイテッド |
ヒストン脱アセチル酵素の抑制
|
|
JP2001081031A
(ja)
|
1999-08-30 |
2001-03-27 |
Schering Ag |
溶解性および経口吸収性を改善したベンズアミド誘導体含有製剤
|
|
TR200201052T2
(tr)
|
1999-09-08 |
2003-01-21 |
Sloan-Kettering Institute For Cancer Research |
Yeni hücre farklılaştırıcı ajanlar sınıfı ve hıstone deacetylase inhibitörleri, ve burada kullanım yöntemleri
|
|
EP1748046A3
(en)
|
1999-11-23 |
2007-08-22 |
Methylgene, Inc. |
Inhibitors of histone deacetylase
|
|
DE60143520D1
(de)
|
2000-03-24 |
2011-01-05 |
Methylgene Inc |
Inhibitoren der histon-deacetylase
|
|
AU2001285042A1
(en)
|
2000-08-18 |
2002-03-04 |
The Governement Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Methods of treating cutaneous and peripheral t-cell lymphoma by a histone deacetylase inhibitor
|
|
PE20020354A1
(es)
|
2000-09-01 |
2002-06-12 |
Novartis Ag |
Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda)
|
|
AU2001290131B2
(en)
|
2000-09-29 |
2007-11-15 |
Topotarget Uk Limited |
Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors
|
|
WO2002055017A2
(en)
|
2000-11-21 |
2002-07-18 |
Wake Forest University |
Method of treating autoimmune diseases
|
|
AR035659A1
(es)
|
2000-12-07 |
2004-06-23 |
Hoffmann La Roche |
Hidroxiamidas de acido (1-oxo-1,2,3,4-tetrahidro-naftalen-2-il)-alcanoico, proceso para la manufactura de estos compuestos, composiciones farmaceuticas que contienen dichos compuestos y los usos de los mismos
|
|
US6495719B2
(en)
*
|
2001-03-27 |
2002-12-17 |
Circagen Pharmaceutical |
Histone deacetylase inhibitors
|
|
US6905669B2
(en)
|
2001-04-24 |
2005-06-14 |
Supergen, Inc. |
Compositions and methods for reestablishing gene transcription through inhibition of DNA methylation and histone deacetylase
|
|
US7199227B2
(en)
*
|
2001-06-14 |
2007-04-03 |
Bristol-Myers Squibb Company |
Polynucleotides encoding human histone deacetylase HDAC9c
|
|
AU2002340253C1
(en)
*
|
2001-10-16 |
2011-03-31 |
Sloan-Kettering Institute For Cancer Research |
Treatment of neurodegenerative diseases and cancer of the brain
|
|
US20040132643A1
(en)
*
|
2002-01-09 |
2004-07-08 |
Fojo Antonio Tito |
Histone deacelylase inhibitors in diagnosis and treatment of thyroid neoplasms
|
|
JP2005525345A
(ja)
*
|
2002-02-15 |
2005-08-25 |
スローン−ケッタリング・インスティテュート・フォー・キャンサー・リサーチ |
Ｔｒｘ媒介性疾患を処置する方法
|
|
US20070060614A1
(en)
*
|
2002-03-04 |
2007-03-15 |
Bacopoulos Nicholas G |
Methods of treating cancer with hdac inhibitors
|
|
US7148257B2
(en)
*
|
2002-03-04 |
2006-12-12 |
Merck Hdac Research, Llc |
Methods of treating mesothelioma with suberoylanilide hydroxamic acid
|
|
US20040132825A1
(en)
*
|
2002-03-04 |
2004-07-08 |
Bacopoulos Nicholas G. |
Methods of treating cancer with HDAC inhibitors
|
|
US20060276547A1
(en)
*
|
2002-03-04 |
2006-12-07 |
Bacopoulos Nicholas G |
Methods of treating cancer with HDAC inhibitors
|
|
CA2632078C
(en)
|
2002-03-04 |
2012-08-14 |
Sloan-Kettering Institute For Cancer Research |
Methods of inducing terminal differentiation
|
|
US7456219B2
(en)
*
|
2002-03-04 |
2008-11-25 |
Merck Hdac Research, Llc |
Polymorphs of suberoylanilide hydroxamic acid
|
|
MXPA04010199A
(es)
*
|
2002-04-15 |
2005-07-05 |
Sloan Kettering Inst Cancer |
Terapia en combinacion para el tratamiento de cancer.
|
|
DE10218106A1
(de)
*
|
2002-04-23 |
2003-11-20 |
Jenapharm Gmbh |
Verfahren zum Herstellen von Kristallen von Arzneimittelwirkstoffen, danach erhältliche Kristalle und deren Verwendung in pharmazeutischen Formulierungen
|
|
AU2003291097A1
(en)
*
|
2002-11-20 |
2004-06-15 |
Errant Gene Therapeutics, Llc |
Treatment of lung cells with histone deacetylase inhibitors
|
|
EP1613592A4
(en)
*
|
2003-04-01 |
2008-03-12 |
Sloan Kettering Inst Cancer |
HYDROXAMIC ACID COMPOUNDS AND METHODS OF USE THEREOF
|
|
RU2356547C2
(ru)
*
|
2003-08-26 |
2009-05-27 |
Мерк ЭйчДиЭйСи Рисерч ЛЛС |
Способы лечения рака с использованием ингибиторов hdac
|
|
TWI415603B
(zh)
*
|
2005-05-20 |
2013-11-21 |
Merck Sharp & Dohme |
１，８－辛二醯基苯胺羥胺酸（ｓｕｂｅｒｏｙｌａｎｉｌｉｄｅ ｈｙｄｒｏｘａｍｉｃ ａｃｉｄ）之調配物及其製配方法
|
|
US20090227674A1
(en)
|
2005-08-18 |
2009-09-10 |
Richon Victoria M |
Combination methods fo saha and targretin for treating cancer
|
|
AU2006311808A1
(en)
|
2005-11-04 |
2007-05-18 |
Merck Sharp & Dohme Corp. |
Methods of using SAHA and bortezomib for treating cancer
|
|
CA2626679C
(en)
|
2005-11-04 |
2011-08-16 |
Merck & Co., Inc. |
Methods of treating cancers with saha, carboplatin, and paclitaxel and other combination therapies
|
|
US20070197568A1
(en)
*
|
2005-11-04 |
2007-08-23 |
Paul Bunn |
Methods of using SAHA and Erlotinib for treating cancer
|